Inotiv offers a comprehensive array of clinical pathology and biomarker services to support projects in animal models, discovery, and preclinical studies. Coupling traditional hematology, coagulation, clinical biochemistry, and urinalysis with targeted, next-generation biomarkers, our specialized pathology laboratory services are available to meet your clinical pathology and biomarker development needs.

We perform integrated and comprehensive pathology evaluations by experienced board-certified veterinary anatomic and clinical pathologists. Our team of pathologists is recognized as scientific leaders in the field of toxicologic pathology and have expertise across a wide spectrum of investigative/research and regulated studies. We can conduct research in accordance with the current standards of Good Laboratory Practice (GLP) and will assure effective application of the latest in biomarker development trends.

Click here to view our presentation: Clinical Pathology Integration in Nonclinical Toxicity Studies: Pulling It All Together.

Capabilities and Services:

  • Hematology
  • Clinical chemistry
  • Coagulation
  • Urinalysis
  • Fluid evaluation
  • Cytopathology
  • Bone marrow smear evaluation services
  • Biomarkers and immunoassay services
    • Method development/optimization
    • Immunology
      • Lymphocyte subtyping
      • Acute phase proteins
      • Cytokines
      • Complement
      • Immunoglobulins
    • Renal Injury
    • Cardiac Injury
    • Diabetes metabolism
    • Iron status
    • Endocrinology/hormones
  • Consultation services
    • Interpretation
    • Study design
    • Clinical pathology/biomarkers
    • Immunotoxicology/vaccine support
  • Assay/method develop
    • Clinical pathology
    • Biomarkers
    • Flow cytometry
    • Interference/troubleshooting

Vice President, Pathology – Adam Aulbach, DVM

Click here to learn more about our pathologists.


Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now